Baş Boyun Kanserlerinde İmplant Tedavisi
Öz
Anahtar Kelimeler
Kaynakça
- 1. Akay AS, Arısan V. Dental Implants in the Medically Compromised Patient Population. Clinical Trials in Vulnerable Populations. 2018:59.
- 2. Anesi A, Di Bartolomeo M, Pellacani A, Ferretti M, Cavani F, Salvatori R, et al. Bone healing evaluation following different osteotomic techniques in animal models: A suitable method for clinical insights. Applied Sciences. 2020;10(20):7165.
- 3. Hwang D, Wang H-L. Medical contraindications to implant therapy: part I: absolute contraindications. Implant dentistry. 2006;15(4):353-60.
- 4. Kovács AF. Influence of chemotherapy on endosteal implant survival and success in oral cancer patients. International journal of oral and maxillofacial surgery. 2001;30(2):144-7.
- 5. Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, et al. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. Journal of oral and maxillofacial surgery. 2014;72(10):1938-56.
- 6. Yu H, Zhou A, Liu J, Tang Y, Yuan Q, Man Y, et al. Management of systemic risk factors ahead of dental implant therapy: A beard well lathered is half shaved. Journal of Leukocyte Biology. 2021.
- 7. Schiegnitz E, Müller LK, Sagheb K, Theis L, Cagiran V, Kämmerer PW, et al. Clinical long-term and patient-reported outcomes of dental implants in oral cancer patients. International Journal of Implant Dentistry. 2021;7(1).
- 8. Nelson K, Heberer S, Glatzer C. Survival analysis and clinical evaluation of implant-retained prostheses in oral cancer resection patients over a mean follow-up period of 10 years. The Journal of prosthetic dentistry. 2007;98(5):405-10.
Ayrıntılar
Birincil Dil
Türkçe
Konular
Sağlık Kurumları Yönetimi
Bölüm
Derleme
Yazarlar
Ece İrem Ravalı
*
Türkiye
Yayımlanma Tarihi
1 Ekim 2021
Gönderilme Tarihi
17 Ağustos 2021
Kabul Tarihi
27 Ekim 2021
Yayımlandığı Sayı
Yıl 2021 Cilt: 7 Sayı: 2